Forecasting The Future: 19 Analyst Projections For Biogen
Forecasting The Future: 19 Analyst Projections For Biogen
預測未來：19位分析師對渤健公司的預測
Throughout the last three months, 19 analysts have evaluated Biogen (NASDAQ:BIIB), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，19位分析師已經評估了Biogen（納斯達克：BIIB），提供了從看好到看淡的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $274.32, a high estimate of $342.00, and a low estimate of $200.00. This current average has decreased by 2.86% from the previous average price target of $282.39.
分析師分析的12個月價格目標提供了一些見解，其中平均目標爲274.32美元，最高估值爲342.00美元，最低估值爲200.00美元。這個當前的均值比之前的平均價格目標282.39美元下降了2.86%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The standing of Biogen among financial experts is revealed through an in-depth...
通過對近期分析師行動的深入...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。